- Home
- PCVX vs CELH Comparison
PCVX vs CELH Comparison
Compare PCVX & CELH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- CELH
- Stock Information
- Founded
- PCVX 2013
- CELH 2004
- Country
- PCVX United States
- CELH United States
- Employees
- PCVX N/A
- CELH N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- CELH Beverages (Production/Distribution)
- Sector
- PCVX Health Care
- CELH Consumer Staples
- Exchange
- PCVX Nasdaq
- CELH Nasdaq
- Market Cap
- PCVX 4.0B
- CELH 16.6B
- IPO Year
- PCVX 2020
- CELH N/A
- Fundamental
- Price
- PCVX $43.85
- CELH $60.50
- Analyst Decision
- PCVX Strong Buy
- CELH Strong Buy
- Analyst Count
- PCVX 8
- CELH 18
- Target Price
- PCVX $114.17
- CELH $64.06
- AVG Volume (30 Days)
- PCVX 1.7M
- CELH 4.0M
- Earning Date
- PCVX 11-05-2025
- CELH 11-07-2025
- Dividend Yield
- PCVX N/A
- CELH N/A
- EPS Growth
- PCVX N/A
- CELH N/A
- EPS
- PCVX N/A
- CELH 0.39
- Revenue
- PCVX N/A
- CELH $1,666,480,000.00
- Revenue This Year
- PCVX N/A
- CELH $84.78
- Revenue Next Year
- PCVX N/A
- CELH $30.62
- P/E Ratio
- PCVX N/A
- CELH $155.52
- Revenue Growth
- PCVX N/A
- CELH 11.85
- 52 Week Low
- PCVX $27.66
- CELH $21.10
- 52 Week High
- PCVX $116.00
- CELH $66.74
- Technical
- Relative Strength Index (RSI)
- PCVX 62.86
- CELH 49.25
- Support Level
- PCVX $41.24
- CELH $60.00
- Resistance Level
- PCVX $45.50
- CELH $62.55
- Average True Range (ATR)
- PCVX 1.59
- CELH 2.23
- MACD
- PCVX -0.22
- CELH -0.47
- Stochastic Oscillator
- PCVX 61.27
- CELH 10.91
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. The firm now owns three energy drink brands: Celsius, Alani Nu, and Rockstar Energy. It dedicates its efforts to product innovation and marketing while outsourcing manufacturing and packaging to third-party co-packers and distribution to PepsiCo. The firm issued convertible preferred shares following PepsiCo's investments in 2022 and 2025, giving the latter an 11% stake in Celsius.